QSAM Biosciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of QSAM Biosciences generated cash of -$2,848,136, which is less than the previous year. Cash used in financing activities reached the amount of $4,009,247 last year. Net change in cash is therefore $1,161,111.
Cash Flow
| 2013 | -88.28K | 0 | 90.27K |
|---|---|---|---|
| 2015 | -1.86M | -88.84K | 1.71M |
| 2016 | -516.83K | -4.01K | 523.16K |
| 2017 | -1.20M | 0 | 1.50M |
| 2018 | -1.06M | -50K | 980K |
| 2019 | -978.05K | 0 | 818.5K |
| 2020 | -742.89K | 0 | 750.72K |
| 2021 | -1.76M | 0 | 3.26M |
| 2022 | -2.71M | 0 | 1.43M |
| 2023 | -2.84M | 0 | 4.00M |
QSAM Cash Flow Statement (2013 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 225.27K | 1.49M | 8.30K | 478 | 160.03K | 298.67K | 3.33K | 1.01K | 265.37K | 59 |
Operating activities | ||||||||||
Net income | -4.39M | -5.48M | -11.97M | -4.86M | -681.97K | -397.25K | -2.71M | -1.49M | -3.53M | -238.37K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 36.3B | 36.3K | 0 | 1.25B | 354 | 199 | 23.12K | 71.27K | 84.25K | 16.53K |
Stock-based compensation expense | 1.25M | 2.01M | 9.00M | 282.99K | 115 | 331 | 445 | 117K | 111.39K | 0 |
| Deferred income tax benefit | 1.25M | 2.01M | 9.00M | 282.99K | 115 | 331 | 445 | 117K | 111.39K | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -142.60K | 155.83K | 283.66K | 174.69K | 43.17K | 54.73K | -72.27K | 355.83K | 15.79K | 0 |
Cash generated by operating activities | -2.84M | -2.71M | -1.76M | -742.89K | -978.05K | -1.06M | -1.20M | -516.83K | -1.86M | -88.28K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | -50K | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.01K | -88.84K | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | -50K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | 0 | -50K | 0 | -4.01K | -88.84K | 0 |
Financing activities | ||||||||||
Common Stock Issued | 4.00M | 1.40M | 2.22T | 100B | 0 | 0 | 0 | 157.5K | 1.21M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -2.19T | -64.56B | 0 | 0 | 0 | 417.86K | 0 | 0 |
Repayments of term debt | 0 | 0 | -33.49K | -1.59K | 0 | -980K | 0 | -8.14K | 0 | 0 |
Cash used in financing activities | 4.00M | 1.43M | 3.26M | 750.72K | 818.5K | 980K | 1.50M | 523.16K | 1.71M | 90.27K |
Net Change In Cash | 1.16M | -1.27M | 1.49M | 7.82K | -159.55K | -138.63K | 295.34K | 2.31K | -264.36K | 1.98K |
Cash at end of period | 1.38M | 225.27K | 1.49M | 8.30K | 478 | 160.03K | 298.67K | 3.33K | 1.01K | 2.04K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |